204 related articles for article (PubMed ID: 21161398)
1. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis comprising 9,911 cases and 11,171 controls.
Sergentanis TN; Economopoulos KP
Mol Biol Rep; 2011 Nov; 38(8):4955-63. PubMed ID: 21161398
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 G870A polymorphism and breast cancer risk: a meta-analysis involving 23,998 subjects.
Yang J; Liu H; Lu S; Gao M; Du Q; Tang SC
Oncol Res; 2011; 19(12):519-25. PubMed ID: 22812184
[TBL] [Abstract][Full Text] [Related]
3. Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis.
Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
Oncotarget; 2016 Oct; 7(40):66109-66118. PubMed ID: 27623072
[TBL] [Abstract][Full Text] [Related]
4. Effects of the cyclin D1 polymorphism on lung cancer risk--a meta-analysis.
Li Y; Zhang S; Geng JX; Yu Y
Asian Pac J Cancer Prev; 2012; 13(5):2325-8. PubMed ID: 22901215
[TBL] [Abstract][Full Text] [Related]
5. AA genotype of cyclin D1 G870A polymorphism increases breast cancer risk: Findings of a case-control study and meta-analysis.
Akhter N; Alzahrani FA; Dar SA; Wahid M; Sattar RSA; Hussain S; Haque S; Ansari SA; Jawed A; Mandal RK; Almalki S; Alharbi RA; Husain SA
J Cell Biochem; 2019 Oct; 120(10):16452-16466. PubMed ID: 31243808
[TBL] [Abstract][Full Text] [Related]
6. The association between CCND1 G870A polymorphism and colorectal cancer risk: A meta-analysis.
Xie M; Zhao F; Zou X; Jin S; Xiong S
Medicine (Baltimore); 2017 Oct; 96(42):e8269. PubMed ID: 29049220
[TBL] [Abstract][Full Text] [Related]
7. Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: a case-control study and meta-analysis.
Liao D; Wu Y; Pu X; Chen H; Luo S; Li B; Ding C; Huang GL; He Z
PLoS One; 2014; 9(11):e113299. PubMed ID: 25409185
[TBL] [Abstract][Full Text] [Related]
8. CCND1 G870A polymorphism contributes to breast cancer susceptibility: a meta-analysis.
Lu C; Dong J; Ma H; Jin G; Hu Z; Peng Y; Guo X; Wang X; Shen H
Breast Cancer Res Treat; 2009 Aug; 116(3):571-5. PubMed ID: 18819000
[TBL] [Abstract][Full Text] [Related]
9. Association of cyclin D1 A870G polymorphism with two malignancies: acute lymphoblastic leukemia and breast cancer.
Bedewy AM; Mostafa MH; Saad AA; El-Maghraby SM; Bedewy MM; Hilal AM; Kandil LS
J BUON; 2013; 18(1):227-38. PubMed ID: 23613410
[TBL] [Abstract][Full Text] [Related]
10. Cyclin D1 (CCND1) G870A gene polymorphism is an ethnicity-dependent risk factor for digestive tract cancers: a meta-analysis comprising 20,271 subjects.
Chen B; Cao L; Yang P; Zhou Y; Wu XT
Cancer Epidemiol; 2012 Apr; 36(2):106-15. PubMed ID: 21606015
[TBL] [Abstract][Full Text] [Related]
11. Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis.
Sergentanis TN; Economopoulos KP
Breast Cancer Res Treat; 2010 Jul; 122(2):459-69. PubMed ID: 20035380
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis.
Zhao Y; He HR; Wang MY; Ren XD; Zhang L; Dong YL; Lu J
Genet Mol Res; 2015 May; 14(2):5171-80. PubMed ID: 26125710
[TBL] [Abstract][Full Text] [Related]
13. Specific CCND1 G870A alleles associated with breast cancer susceptibility: a meta-analysis of 5,528 cases and 5,353 controls.
Cui J; Shen L; Wang Y
Asian Pac J Cancer Prev; 2012; 13(10):5023-5. PubMed ID: 23244103
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis.
Liu J; Liao Q; Zhang Y; Sun S; Zhong C; Liu X
Tumour Biol; 2012 Oct; 33(5):1467-76. PubMed ID: 22528945
[TBL] [Abstract][Full Text] [Related]
15. Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls.
Hu YY; Zheng R; Guo C; Niu YM
Diagn Pathol; 2014 Sep; 9():168. PubMed ID: 25204741
[TBL] [Abstract][Full Text] [Related]
16. CCND1 G870A polymorphism interaction with cigarette smoking increases lung cancer risk: meta-analyses based on 5008 cases and 5214 controls.
Duan YZ; Zhang L; Liu CC; Zhu B; Zhuo WL; Chen ZT
Mol Biol Rep; 2013 Jul; 40(7):4625-35. PubMed ID: 23653001
[TBL] [Abstract][Full Text] [Related]
17. CCND1 G870A polymorphism and cervical cancer risk: a case-control study and meta-analysis.
Ni J; Wang M; Wang M; Fu S; Zhou D; Zhang Z; Han S
J Cancer Res Clin Oncol; 2011 Mar; 137(3):489-94. PubMed ID: 20473525
[TBL] [Abstract][Full Text] [Related]
18. Cyclin D1 G870A polymorphism contributes to colorectal cancer susceptibility: evidence from a systematic review of 22 case-control studies.
Yang Y; Wang F; Shi C; Zou Y; Qin H; Ma Y
PLoS One; 2012; 7(5):e36813. PubMed ID: 22606291
[TBL] [Abstract][Full Text] [Related]
19. Lack of association between CCND1 G870A polymorphism and the risk of breast and colorectal cancers.
Grieu F; Malaney S; Ward R; Joseph D; Iacopetta B
Anticancer Res; 2003; 23(5b):4257-9. PubMed ID: 14666635
[TBL] [Abstract][Full Text] [Related]
20. Three polymorphisms in cytochrome P450 1B1 (CYP1B1) gene and breast cancer risk: a meta-analysis.
Economopoulos KP; Sergentanis TN
Breast Cancer Res Treat; 2010 Jul; 122(2):545-51. PubMed ID: 20054638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
